Certified by Founder Lodge
RiverVest Venture Partners
United States - St. Louis, MO
INVESTOR
1 Disclosed Funding Rounds $14,000,000
12 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
RiverVest Venture Partners® is a leading venture capital firm building life science companies to address significant unmet needs of patients and deliver consistently strong returns to investo
| Company | Date | Round | Raised |
|---|---|---|---|
 Alleviant Medical |
January, 16 ,2025 | Unknown | $90,000,000 |
 OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Atalanta Therapeutics |
January, 29 ,2025 | Series B | $75,000,000 |
 Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
 Glycomine Inc. |
April, 17 ,2025 | Series C | $115,000,000 |
 Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
 InterVene, Inc. |
October, 08 ,2024 | Series A | $13,000,000 |
| Alleviant Medical |
January, 16 ,2025 | Unknown | $90,000,000 |
| Atalanta Therapeutics |
January, 29 ,2025 | Series B | $75,000,000 |
| Glycomine Inc. |
April, 17 ,2025 | Series C | $115,000,000 |
 Sparrow Pharmaceuticals, Inc. |
September, 25 ,2025 | Series B | $95,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
